ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 143 filers reported holding ANI PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,364,799 | +3.5% | 247,413 | -4.1% | 0.01% | +25.0% |
| Q2 2023 | $13,883,403 | +15.9% | 257,912 | -14.5% | 0.00% | 0.0% |
| Q1 2023 | $11,978,161 | -1.3% | 301,565 | -0.0% | 0.00% | 0.0% |
| Q4 2022 | $12,133,000 | +23.3% | 301,595 | -1.5% | 0.00% | 0.0% |
| Q3 2022 | $9,842,000 | +9.3% | 306,210 | +0.9% | 0.00% | +33.3% |
| Q2 2022 | $9,005,000 | +2.2% | 303,508 | -3.2% | 0.00% | 0.0% |
| Q1 2022 | $8,813,000 | -32.4% | 313,473 | +10.7% | 0.00% | -25.0% |
| Q4 2021 | $13,045,000 | +45.1% | 283,077 | +3.3% | 0.00% | +33.3% |
| Q3 2021 | $8,992,000 | -6.8% | 273,945 | -0.5% | 0.00% | 0.0% |
| Q2 2021 | $9,649,000 | +9.7% | 275,267 | +13.1% | 0.00% | 0.0% |
| Q1 2021 | $8,795,000 | +29.6% | 243,333 | +4.1% | 0.00% | +50.0% |
| Q4 2020 | $6,785,000 | +15.2% | 233,646 | +11.9% | 0.00% | 0.0% |
| Q3 2020 | $5,890,000 | +240.1% | 208,773 | +289.8% | 0.00% | +100.0% |
| Q2 2020 | $1,732,000 | -25.0% | 53,565 | -5.4% | 0.00% | 0.0% |
| Q1 2020 | $2,308,000 | -32.1% | 56,643 | +2.8% | 0.00% | 0.0% |
| Q4 2019 | $3,400,000 | -18.8% | 55,127 | -4.1% | 0.00% | -50.0% |
| Q3 2019 | $4,187,000 | -54.6% | 57,458 | -48.8% | 0.00% | -50.0% |
| Q2 2019 | $9,227,000 | +11.4% | 112,261 | -4.4% | 0.00% | 0.0% |
| Q1 2019 | $8,281,000 | +36.7% | 117,391 | -12.8% | 0.00% | +33.3% |
| Q4 2018 | $6,058,000 | -23.8% | 134,563 | -4.3% | 0.00% | 0.0% |
| Q3 2018 | $7,952,000 | +43.2% | 140,658 | +69.2% | 0.00% | +50.0% |
| Q2 2018 | $5,552,000 | +75.9% | 83,125 | +53.3% | 0.00% | +100.0% |
| Q1 2018 | $3,157,000 | -7.7% | 54,229 | +2.2% | 0.00% | -50.0% |
| Q4 2017 | $3,419,000 | +21.2% | 53,045 | -1.3% | 0.00% | +100.0% |
| Q3 2017 | $2,821,000 | +11.2% | 53,760 | -0.8% | 0.00% | 0.0% |
| Q2 2017 | $2,536,000 | -4.9% | 54,205 | +0.6% | 0.00% | 0.0% |
| Q1 2017 | $2,667,000 | -16.8% | 53,865 | +1.9% | 0.00% | -50.0% |
| Q4 2016 | $3,204,000 | -6.6% | 52,865 | +2.2% | 0.00% | 0.0% |
| Q3 2016 | $3,431,000 | +25.8% | 51,712 | +5.8% | 0.00% | 0.0% |
| Q2 2016 | $2,728,000 | +88.8% | 48,885 | +13.8% | 0.00% | +100.0% |
| Q1 2016 | $1,445,000 | -22.1% | 42,960 | +4.6% | 0.00% | 0.0% |
| Q4 2015 | $1,854,000 | -26.8% | 41,080 | -35.9% | 0.00% | -50.0% |
| Q3 2015 | $2,533,000 | -38.7% | 64,110 | -3.8% | 0.00% | 0.0% |
| Q2 2015 | $4,134,000 | +4.3% | 66,637 | +5.2% | 0.00% | 0.0% |
| Q1 2015 | $3,963,000 | +31.4% | 63,360 | +18.5% | 0.00% | 0.0% |
| Q4 2014 | $3,015,000 | +333.2% | 53,465 | +117.3% | 0.00% | – |
| Q3 2014 | $696,000 | +68.9% | 24,605 | +105.9% | 0.00% | – |
| Q2 2014 | $412,000 | – | 11,950 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |